| Value | ₹3,756 Cr |
|---|
BSE filing, NSE: JINDALSAW. Summary written from the filing by ALFA Finder's alert engine.
Jindal Saw Ltd: key numbers
- Share price
- ₹228.05
- Market cap
- ₹14,584 Cr
- Revenue (annual)
- ₹17,895 Cr
- Net profit (annual)
- ₹973.4 Cr
- P/E (TTM)
- 26.6×Sector 16.5×
- Promoter holding
- 63.24%-0.01% QoQ
- FII holding
- 11.32%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jindal Saw Ltd
All →Jindal Saw Earnings Call Transcript: Key Takeaways
Revenue growth is masked by severe EBITDA compression due to geopolitical delays in the MENA region and rising raw material costs.
Jindal Saw Debt & Borrowing
Jindal Saw Ltd. submitted its Security Cover Certificate for the quarter ended September 30, 2026, as per Regulation 54(3) of SEBI listing regulations.
Jindal Saw Other Announcement
Jindal Saw Ltd. filed its quarterly statement confirming the utilization of NCD proceeds as per SEBI regulations. No deviations were reported for the period.
Jindal Saw Investor Presentation: Key Takeaways
Jindal Saw reports Q2 FY27 consolidated revenue of ₹45,231 Million with PAT at ₹353 Million. Performance was severely impacted by MENA regional instability and domestic water pipe headwinds.
Jindal Saw Q2 FY27 Results: Net Profit ₹35.3 Cr, Down 74.5% YoY
Jindal Saw Ltd reported revenue from operations of ₹4,472 Cr (+5.6% YoY) and net profit of ₹35.3 Cr (-74.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹35.3 Cr · -74.5% YoY
Jindal Saw Board Meeting Date
Jindal Saw Ltd has scheduled a board meeting for October 16, 2026. The board will consider and approve unaudited financial results for the quarter ended September 30, 2026.
Other results update announcements
All →Wonderla Holidays Results Update
Wonderla reports best-ever Q2 with 42% income growth to ₹126 Cr and 90% EBITDA growth. H1 income up 41% to ₹378 Cr driven by new Chennai park.
UPL Results Update
UPL's Q2 FY27 revenue was ₹11,860 Cr with EBITDA of ₹2,312 Cr. H1 operational PATMI rose 33% YoY on sustained margin expansion.
Procter & Gamble Health Results Update
P&G Health's Q2 sales grew 18% to ₹376 crore and PAT rose 26% to ₹112 crore. Growth driven by brand strength and retail execution.
JTL Defence Results Update
JTL Defence reported H1 FY27 revenue of Rs.410 Cr, up 11.4x YoY, with EBITDA of Rs.47 Cr. Adjusted PAT of Rs.3 Cr was impacted by asset revaluation depreciation.
Mold-Tek Packaging Results Update
Mold-Tek reported Q2 FY27 net profit up 36% to Rs 21.06 Cr and H1 profit up 23% to Rs 46.67 Cr. Revenue and sales volumes also rose across both periods.
Epigral Results Update
Epigral reported Q2 FY27 PAT of ₹64 Cr, up 26% YoY, with revenue at ₹752 Cr. EBITDA margin was 18% despite elevated raw material costs.